Company at Center of Drug Price-Gouging Storm Cuts Cost of Medicine. But The 50% cut, to about $375 a pill, is too little to offset Turing's earlier price hike for a decades old drug. It remains available in Europe for under $1 a pill.

Turing Pharmaceuticals, the company that became a lightning rod for criticism over excessive price increases for older medicines, on Tuesday said it would cut the cost of its anti-infection drug to hospitals.

Privately-held Turing and its Chief Executive Martin Shkreli sparked outrage in September after it acquired the rights to a 62-year-old drug, Daraprim, and raised the price more than 5,000 percent to $750 a pill from $13.50.

The company said it will offer reductions of up to 50 percent off its previously announced price for hospitals, which handle about 80 percent of cases of toxoplasmosis encephalitis, the dangerous infection that Daraprim is used to treat.

This entry passed through the Full-Text RSS service - if this is your content and you're reading it on someone else's site, please read the FAQ at http://ift.tt/jcXqJW.

http://ift.tt/1XdAmYL Company at Center of Drug Price-Gouging Storm Cuts Cost of Medicine. But The 50% cut, to about $375 a pill, is too little to offset Turing's earlier price hike for a decades old drug. It remains available in Europe for under $1 a pill. via top scoring links : news http://ift.tt/1lhytbU

Put the internet to work for you.

Turn off or edit this Recipe